Evidence map›Paper›PMID 36070402›Full record

ArticleHypertension (Dallas, Tex. : 1979)2022

Angiotensin Receptor Blockers and Dementia Prevention: Do Not RAS to a Conclusion Yet.

Sevil Yasar, Whitney Wharton

Abstract readEditorialComment
PubMed Full text at PMC Publisher
In one paragraph

Article in Hypertension (Dallas, Tex. : 1979), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

2 authors.

Sevil YasarDepartment of Medicine, Johns Hopkins School of Medicine, Baltimore, MD (S.Y.).ORCID 0000-0002-5080-6534
Whitney WhartonSchool of Nursing, Emory University, Atlanta, GA (W.W.).ORCID 0000-0002-6863-5104

Funding

ARIC Neurocognitive Study (ARIC-NCS) Renewal 2023-2028U01HL096812 · NHLBI · NEW YORK UNIVERSITY SCHOOL OF MEDICINE · PI JOSEF CORESH, THOMAS H MOSLEY · 2010 to 2026
$65.7M
Role of estradiol and related hormones on inflammation, sleep, and risks for Alzheimer's diseaseR01AG066203 · NIA · EMORY UNIVERSITY · PI HU, WILLIAM TZU-LUNG, WHARTON, WHITNEY LEE · 2019 to 2023
$3.6M
Inflammation and Renin-Angiotensin System Dysfunction as risk factors for ADRF1AG051514 · NIA · EMORY UNIVERSITY · PI NORRIS, CHRISTOPHER MARK, WALKER, LARY C · 2015 to 2017
$3.6M
Effects of the renin angiotensin system on MRI volumetric measures and cognitive function in the Alzheimer's disease process: the LookAHEAD studyR01AG074258 · NIA · JOHNS HOPKINS UNIVERSITY · PI YASAR, SEVIL · 2022 to 2024
$1.5M
Relation of angiotensin converting enzyme (ACE) and angiotensin II (ANGII) to MRI volumetric measures from community based studyR03AG058043 · NIA · JOHNS HOPKINS UNIVERSITY · PI YASAR, SEVIL · 2018 to 2019
$164k
NHLBI NIH HHS U01 HL096812NIA NIH HHS R01 AG066203NIA NIH HHS R01 AG074258NIA NIH HHS R03 AG058043NIA NIH HHS RF1 AG051514
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Angiotensin Receptor AntagonistsDementiaAngiotensin-Converting Enzyme InhibitorsHumansRenin-Angiotensin SystemAngiotensin-Converting Enzyme InhibitorsAngiotensin Receptor Antagonists

Identifiers

PMID36070402
PMCPMC9472812

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.